The metformin hydrochloride extended-release tablets are commonly given to patients to lower their glucose levels and are sold under the brand name Time-Cap Labs, Inc. This recall applies to the tablets of 500 mg and 750 mg in size. A similar product recall started earlier this summer and seven other pharmaceutical companies have now issued recalls for similar reasons. Most tablets that use NDMA do so at a safe level. What is unclear—and currently under investigation by the FDA—is where NDMA comes from originally and how it has ended up in these recalled products in the quantities it has. The FDA has issued a list of the products to which the latest recall applies, with National Drug Code numbers to allow identification. The tablets are either embossed with the numbers 101 or 102 on one side, and are unmarked on the other. If you have any of these in your medicine cabinet, contact your doctor and pharmacy for further advice. Most importantly, the FDA advises that “patients taking recalled metformin should continue taking it until a doctor or pharmacist gives them a replacement or a different treatment option. It could be dangerous for patients with type-2 diabetes to stop taking their metformin without first talking to their health care professional. Patients should return unused recalled metformin to their pharmacist when they get their new medication.” For more products being banned, check out The FDA Just Recalled 21 Popular Dog Foods for This Terrifying Reason. And here are the recalled metformin hydrochloride extended-release tablets to look out for: Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 90 counts: 49483-623-09 100 counts: 49483-623-01 500 counts: 49483-623-50 1000 counts: 49483-623-10 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 100 counts: 49483-624-01 And for more recent medical recalls, read on. Acella Pharmaceuticals, LLC recalled their 15-mg and 120-mg NP Thyroid thyroid tablets, after testing found them to be sub potent. The product may have as low as 87 percent of the labeled amount of the key ingredient levothyroxine, the FDA reports. This male enhancement tablet was recalled entirely by its manufacturer, The Protein Shoppe, due to the presence of the undeclared ingredient sildenafil. “The presence of sildenafil in Red-E renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall,” the FDA notes. Maison Terre recalled all lots of its Goldenseal Root Powder, after an FDA laboratory analysis found the powder to be “contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others.“ae0fcc31ae342fd3a1346ebb1f342fcb Select lots of Kore Organic’s Watermelon CBD Oil Tincture were recalled after the Florida Department of Agriculture and Consumer Services tested a random sample of the product and found that it contained high levels of lead.
